A. Abayomi, N. Adomakoh and S. Adomakoh, “Respond?ng to the HIV Epidemic in the Developing World. Capacity Building and Technology Transfer for Monitoring with HAART; A Caribbean Experience,” African Journal of Medicine & Medical Sciences, Vol. 34, 2005, pp. 19-24.
 D. O. Olaleye, T. O. Harry and G. N. Odaibo, “The Virology and Dynamics of the Epidemic in Nigeria,” In: O. Adeyi, P. J. Kanki, O. Odutolu and J. A. Idoko, Eds., Aids in Nigeria: A Nation on the Threshold, Harvard Centre for Population and Development Studies, Cambridge 2006, pp. 37-66.
 J. M. Pascale, M. D. Isaacs, P. Contreras, B. Gomez, L. Lozano, E. Austin, M. C. De Martin, R. L. Gregory, McLaughlin and A. Amador, “Immunological Markers of Disease Progression in Patients Infected with the Human Imunodeficiency Virus,” Clinical and Vaccine Immunology, Vol. 4, No.4, 1997, pp. 474-477.
 O. G. Arinola, L. S. Salimonu, O. H. Okiwelu and C. P. Muller, “Levels of Immunoglobulin Classes, Acute Phase Proteins and Serum Electrophoresis in Nigerians Infected with Human Immmunodeficiency Virus,” European Journal of Scientific Research, Vol. 7, No. 3, 2005, pp. 34-44.
 O. G. Arinola and J. Igbi, “Serum Immunoglobulins and Circulating Immune Complexes in Nigerians with Human Immmunodeficiency Virus and Pulmonary Tuberculosis Infection,” Tropical Journal of Medical Research, Vol. 2, No. 2, 1998, pp. 41- 48.
 E. F. Lyamuya, S. Y. Maselle and R. Matre, “Serum Immunoglobulin Profile in Asymptomatic HIV-1 Seropositive Adults and in Patients with AIDS in Dares Salaam Tanzania,” East African Medical Journal, Vol. 71, No. 1, 1994, pp. 24-28.
 E. S. Lugada, J. Mermin, B. Asjo, F. Kaharuza, R. Downing, N. Langeland, V. Ormaasen, J. Bruun, A. C. Awor and E. Ulvestad, “Immunoglobulin Levels Amongst Persons with and without HIV-1 Infection in Uganda and Norway,” Scandinavian Journal of Immunology, Vol. 59, 2004, pp. 203-208. doi:10.1111/j.0300-9475.2004.01376.x
 S. Moir, A. Malaspina, K. M. Ogwaro, E. T. Donoghue, C. W. Hallahan, L. A. Ehler, S. Liu, J. Adelsberger, R. Lapointe, P. Hwu, M. Baseler, J. M. Orenstein, T. W. Chun, J. A. Mican and A. S. Fauci, “HIV-1 Induces Phenotypic and Functional Perturbations of B Cells in Chronically in Fected Individuals,” Proceedings of the National Academy of Sciences of the USA, Vol. 98, No. 18, 2001, pp. 10362-10367. doi:10.1073/pnas.181347898
 B. A. I. Payne, D. A. Price, M. L. Schmid, E. Ong and M. H. Snow, “High Serum Protein and Gammaglobulins in Black Africans with HIV Infection—Is It Clinically Significant?” Journal of Infection, Vol. 54, No. 3, 2006, pp. e195-e196. doi:10.1016/j.jinf.2006.10.020
 S. H. Mehta, J. Astemborski, T. R. Sterling, D. L. Thomas and D. Vlahov, “Serum Albumin as a Prognostic Indicator for HIV Disease Progression,” AIDS Research and Human Retroviruses, Vol. 22, No. 1, 2006, pp. 14-21. doi:10.1089/aid.2006.22.14
 J. G. Feldman, S. J. Gange, P. Bacchetti, M. Cohen, M. Young, K. E. Squires, C. Williams, P. Goldwasser and K. Anastos, “Serum Albumin Is a Powerful Predictor of Survival among HIV-1 Infected Women,” Journal of Acquired Immune Deficiency Syndromes, Vol. 33, 2003, pp. 66-73. doi:10.1097/00126334-200305010-00010